company background image
BIO.B logo

Bio-Rad Laboratories NYSE:BIO.B Stock Report

Last Price

US$265.82

Market Cap

US$8.2b

7D

0%

1Y

n/a

Updated

18 Mar, 2025

Data

Company Financials +

Bio-Rad Laboratories, Inc.

NYSE:BIO.B Stock Report

Market Cap: US$8.2b

BIO.B Stock Overview

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. More details

BIO.B fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Bio-Rad Laboratories, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bio-Rad Laboratories
Historical stock prices
Current Share PriceUS$265.82
52 Week HighUS$359.22
52 Week LowUS$265.82
Beta0.99
1 Month Change-14.81%
3 Month Change-18.42%
1 Year Changen/a
3 Year Change-54.69%
5 Year Change-19.93%
Change since IPO10,899.45%

Recent News & Updates

Recent updates

Bio-Rad: Sartorius Arb Trade Has Fully Unwound, For Now

Jul 12

Shareholder Returns

BIO.BUS Life SciencesUS Market
7D0%0.4%1.7%
1Yn/a-18.8%10.0%

Return vs Industry: Insufficient data to determine how BIO.B performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how BIO.B performed against the US Market.

Price Volatility

Is BIO.B's price volatile compared to industry and market?
BIO.B volatility
BIO.B Average Weekly Movementn/a
Life Sciences Industry Average Movement9.7%
Market Average Movement6.5%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market3.4%

Stable Share Price: BIO.B's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BIO.B's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19527,700Norman Schwartzwww.bio-rad.com

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications.

Bio-Rad Laboratories, Inc. Fundamentals Summary

How do Bio-Rad Laboratories's earnings and revenue compare to its market cap?
BIO.B fundamental statistics
Market capUS$8.17b
Earnings (TTM)-US$1.84b
Revenue (TTM)US$2.57b

3.2x

P/S Ratio

-4.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIO.B income statement (TTM)
RevenueUS$2.57b
Cost of RevenueUS$1.19b
Gross ProfitUS$1.38b
Other ExpensesUS$3.22b
Earnings-US$1.84b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-58.32
Gross Margin53.73%
Net Profit Margin-71.86%
Debt/Equity Ratio18.1%

How did BIO.B perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/18 21:48
End of Day Share Price 2025/03/03 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bio-Rad Laboratories, Inc. is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Jon WoodBofA Global Research
Sel HardyCFRA Equity Research